We believe providers are at their best when they have easy and fast access to best practices developed by actual providers, supported by evidence, and fully vetted by the broader community. The Test Appropriate CDSM efficiently supplies best practices and supporting information at the point of care to improve care quality, ease compliance, lessen over AND underutilization, and increase workflow efficiency.
We present interactive appropriate use criteria from leading medical societies and providers to ensure compliance and assist in providing the best, most consistent and safest care possible. Consider adding your own protocols to further refine best practices at your organization.
In addition to eliminating inappropriate tests, the Test Appropriate CDSM supplies comparison cost data before orders are placed to guide clinicians to the most appropriate and most cost effective tests and procedures.
We deliver detailed guidance and other critical information when you need it most to improve team workflow efficiency. Customizable features provide assistance with coding, precise payer pricing, minimize referral leakage and assist with payer pre-authorization and reimbursement.
Appropriate Use Criteria (AUC) in their native form are often lengthy and complex, and moreover, change periodically based on the latest research and technology. As such they are impossible to memorize… and why should you? The Test Appropriate CDSM provides fast, interactive access to AUC with the fewest possible clicks to all but eliminate the chance of inappropriate ordering. Our tool also documents AUC consultation to prove compliance, standardize care and reduce liability exposure because the best defense against mal-practice is best practice.
Cost comparison data is displayed (if desired) before orders are placed to guide clinicians to the best test or procedure, not just an appropriate one. Consider that the ACC’s criteria covering seven common tests used to identify ischemia produce an average of 3.3 tests that are appropriate for any given set of patient conditions. Moreover, 59% of the time these appropriate tests include a test in both the lowest and highest cost ranges (roughly $200 vs $3,000). Our chart studies prove that astronomical rates of return are possible from providers on cost sharing models making only modest improvements in lower cost ordering. Alternately, we know that many useful but expensive tests are not being ordered, when they may be the best appropriate choice. However, clinicians simply don’t have the tools to easily know when those scenarios arise because they are far too complex to memorize and require detailed knowledge of each patient’s history that is often times not present in the EHR.
* Calculations based on Test Appropriate chart reviews and applying the ACCF / AHA / ASE / ASNC / HFSA / HRS / SCAI / SCCT / SCMR / STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease.
Medical errors are the third leading cause of death in the United States
$700 billion could be saved without worsening health outcomes
"Excessive testing costs $200 billion to $250 billion (per year)"
Questions? Interested in a demo? Please complete the information below and someone will reply shortly.